[go: up one dir, main page]

AU2001273245A1 - Modulators of trk protein activity, compositions and uses - Google Patents

Modulators of trk protein activity, compositions and uses

Info

Publication number
AU2001273245A1
AU2001273245A1 AU2001273245A AU7324501A AU2001273245A1 AU 2001273245 A1 AU2001273245 A1 AU 2001273245A1 AU 2001273245 A AU2001273245 A AU 2001273245A AU 7324501 A AU7324501 A AU 7324501A AU 2001273245 A1 AU2001273245 A1 AU 2001273245A1
Authority
AU
Australia
Prior art keywords
modulators
compositions
protein activity
trk protein
trk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273245A
Inventor
Alan Thomas Bates
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pangene Corp
Original Assignee
Pangene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pangene Corp filed Critical Pangene Corp
Publication of AU2001273245A1 publication Critical patent/AU2001273245A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychology (AREA)
  • Food Science & Technology (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2001273245A 2000-07-05 2001-07-05 Modulators of trk protein activity, compositions and uses Abandoned AU2001273245A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21577800P 2000-07-05 2000-07-05
US60/215,778 2000-07-05
PCT/US2001/021472 WO2002003071A2 (en) 2000-07-05 2001-07-05 Modulators of trk protein activity, compositions and uses

Publications (1)

Publication Number Publication Date
AU2001273245A1 true AU2001273245A1 (en) 2002-01-14

Family

ID=22804345

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273245A Abandoned AU2001273245A1 (en) 2000-07-05 2001-07-05 Modulators of trk protein activity, compositions and uses

Country Status (2)

Country Link
AU (1) AU2001273245A1 (en)
WO (1) WO2002003071A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7196061B2 (en) * 2003-09-10 2007-03-27 Wyeth Compounds that modulate neuronal growth and their uses
CN1897977A (en) * 2003-10-20 2007-01-17 Ns基因公司 In vivo gene therapy of parkinson's disease
JP2008029296A (en) * 2006-07-31 2008-02-14 Hisamitsu Pharmaceut Co Inc Neuroblastic therapeutic agent, screening method thereof, and method of determining prognosis of neuroblastic
KR102709884B1 (en) 2017-11-30 2024-09-26 리제너론 파마슈티칼스 인코포레이티드 Nonhuman animals containing humanized TRKB locus
WO2022009992A1 (en) * 2020-07-10 2022-01-13 国立大学法人東京大学 Cyclic peptide, peptide complex, and drug composition containing said cyclic peptide and/or said peptide complex

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA922947B (en) * 1991-04-23 1993-01-27 Regeneron Pharma Assay systems for neurotrophin activity
WO1999033482A1 (en) * 1997-12-31 1999-07-08 University Of Utah Research Foundation Uses of alpha-conotoxin peptides

Also Published As

Publication number Publication date
WO2002003071A3 (en) 2003-01-30
WO2002003071A2 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
AU2002326948A1 (en) Piperizinones as modulators of chemokine receptor activity
AU2002232819A1 (en) Methods for the production of multimeric proteins, and related compositions
AU3730600A (en) Compositions preparations and uses of human papillomavirus l1 protein
AU5567700A (en) Hair composition
AU2208401A (en) Inhibitors of complement activation, their preparation and use
AU2001293728A1 (en) Cosmetic composition
AU2001248215A1 (en) Cosmetically active composition
AU2002241508A1 (en) Membrane derived caspase-3, compositions comprising the same and methods of use therefor
AU2001252600A1 (en) Urea-containing gel preparation
AU2001292292A1 (en) Novel enzyme having beta-glucosidase activity and use thereof
AU2002230788A1 (en) Multiplexed protein expression and activity assay
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU2001273245A1 (en) Modulators of trk protein activity, compositions and uses
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
WO2002077233A8 (en) 38650, 28472, 5495, 65507, 81588 and 14354 METHODS AND COMPOSITIONS OF HUMAN PROTEINS AND USES THEREOF
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AR026890A1 (en) COMPOSITIONS OF TENOCITS, PREPARATIONS AND USES
AU2001271281A1 (en) Novel compositions for the expression of the human peptide histidine transporter1 and methods of use thereof
AU2002227928A1 (en) Cosmetic composition
AUPQ599500A0 (en) Novel peptides, modulatory agents therefor and methods of using them
AU2001297794A1 (en) Methods and compositions of human proteins and uses thereof.
AU2001238091A1 (en) Tgf-beta therapeutics, compositions and methods of use